Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

MET-233I

A Study of MET233 in Individuals With Obesity or Overweight

Pfizer · Phase 1 · Completed · Enrollment 144

NCT07022977

ArmPopulationDoseWeeksEstimandWeight change
(Part A) MET233Obesity or overweightn/r12n/rn/r
(Part A) PlaceboObesity or overweightn/r12n/rn/r
(Part B) MET233Obesity or overweightn/r12n/rn/r
(Part B) PlaceboObesity or overweightn/r12n/rn/r
(Part C) MET233Obesity or overweightn/r12n/rn/r
(Part C) PlaceboObesity or overweightn/r12n/rn/r
(Part D) MET233Obesity or overweightn/r12n/rn/r
(Part D) PlaceboObesity or overweightn/r12n/rn/r